RÉSUMÉ
Objective To estimate the pharmacoeconomics of two remedy scheme in curing acute cerebral infarction. Method In 212 cases with acute cerebral infarction patients, 206 cases were adopted, and randomly divided into two group. Group A was 102 cases and Group B was 104 cases. Group A was administered with 18 ml cattle encephalon glycoside which was added into 250 ml 5%glucose injection, ivgtt, qd. After 7 days it was administered compound Butylphthalide Soft Capsules, 0.2 g qid, combined Xiaoshuantongluo capsule, 2.1 g tid until 14 days later. Group B was administered with cattle encephalon glycoside and ignotin injection 18 ml which was added into 250 ml 5%glucose injection, ivgtt, qd until 14 days. The basic therapy of two groups were same. After therapy compared the safety and clinic curative effect from European Stroke Scale(ESS) and activities of daily living(ADL).Then outcome-effectiveness was assayed in pharmacoeconomics. Results The total effective rate were 92.2 and 95.2%,and ccurrence of adverse react were 4.7 and 7.5, respectively,in the two group.The clinic total effective rate counting C/E was respectively 129.1 and 178.5;ΔC/ΔE was 1697.7. Conclusion The clinic curative effect of two group was intimate, but the cost had signiifcant difference. The sequential antimicrobial therapy in curing acute cerebral infarction had excellent advantage in outcome-effectiveness.
RÉSUMÉ
Objective To observe the effect of HuaTanTongLuo decoction on ischemic apoplexy of pathogenic wind and phlegm-blood stasis syndrome in the convalescent stage. Methods 57 patients of ischernic apoplexy were randomly recruited in to a control group and a treatment group. The treatment group containing 29 patients was treated with HuaTanTongLuo decoction, and the control group containing 28 patients was treated with XiaoShuanTongLuo capsule. Evaluate the effects after being treated for 8 weeks. Results The score of neurologic impairment evaluation in both groups was obviously improved in both groups (P<0.01) , with the results in the treatment group being better than the control group (P<0.05) . The therapeutic effect of the treatment group was also better than that of the control group (P<0.05). Conclusion HuaTanTongLuo decoction has effects in treating ischemic apoplexy of pathogenic wind and phlegm-blood stasis syndrome in the convalescent stage.